CLINICAL TRIAL OF THE PANDEMIC INFLUENZA MONOVALENT VACCINE PANDEFLU

CLINICAL TRIAL OF THE PANDEMIC INFLUENZA MONOVALENT VACCINE PANDEFLU

Abstract. Evaluation of reactogenicity, safety and immunogenicity of the inactivated subunit influenza vaccine adsorbed monovalent (Pandeflu) on the base of strain A/California/7/2009 (H1N1v) was conducted in 70 volunteers aged 18–60 years immunized by one or two doses. A clinical trial of the vacci...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: M. K. Erofeeva, V. L. Maksakova, I. Y. Nickonorov, M. G. Pozdnyakova, O. S. Kotova, E. A. Okhapkina, V. D. Evgrafov, E. M. Voicehovskaya, A. A. Vasilyeva, M. A. Stukova, D. S. Bushmenkov, A. A. Romanova, O. I. Kiselev
Formato: article
Lenguaje:RU
Publicado: Sankt-Peterburg : NIIÈM imeni Pastera 2014
Materias:
clinical trials
pandemia
influenza
vaccine
pandeflu
Infectious and parasitic diseases
RC109-216
Acceso en línea:https://doaj.org/article/c2a2b5bb3d9c497b9eba6028679e79ee
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/c2a2b5bb3d9c497b9eba6028679e79ee

Ejemplares similares